Treatment of Acute Asthma Exacerbation with Lower Respiratory Tract Infection

Initial Assessment and Severity Classification

The American College of Chest Physicians recommends immediately assessing severity using objective measurements to avoid underestimating exacerbation severity, with severe exacerbation features including inability to complete sentences in one breath, respiratory rate >25 breaths/min, heart rate >110 beats/min, and PEF <50% predicted 1, 2
Life-threatening features include PEF <33% predicted, silent chest, cyanosis, altered mental status, PaCO₂ ≥42 mmHg, and feeble respiratory effort 1, 2

The American Thoracic Society recommends administering high-flow oxygen (40-60%) immediately via face mask or nasal cannula to maintain SaO₂ >90% (>95% in pregnant patients or those with cardiac disease) 1, 2, 3

The National Asthma Education and Prevention Program recommends albuterol 2.5-5 mg via nebulizer or 4-8 puffs via MDI with spacer every 20 minutes for 3 doses, then 2.5-10 mg every 1-4 hours as needed 1, 2, 3
For severe exacerbations (PEF <40% predicted), consider continuous nebulization of albuterol 1, 2

The American College of Emergency Physicians recommends administering prednisone 40-60 mg orally or hydrocortisone 200 mg IV within the first hour 1, 2, 3

The Infectious Diseases Society of America recommends antibiotics only when there is strong evidence of bacterial infection, such as radiographic evidence of pneumonia, purulent sputum with fever, or clinical sinusitis 1, 4
For community-acquired LRTI requiring antibiotics, the first-line choice is aminopenicillin for 5-7 days 4

The American Academy of Allergy, Asthma, and Immunology recommends reassessing 15-30 minutes after initial treatment: measure PEF, assess symptoms and vital signs 1, 2
Response to treatment is a better predictor of hospitalization need than initial severity 1, 3

The European Respiratory Society recommends admitting patients with life-threatening features persisting after initial treatment, PEF <40% predicted after 1-2 hours of treatment, severe exacerbation features with inadequate response, or presentation in afternoon/evening with recent nocturnal symptoms or previous severe attacks 1, 2, 4

The American College of Chest Physicians recommends discharging when PEF ≥70% of predicted or personal best, symptoms are minimal or absent, oxygen saturation is stable on room air, and the patient is stable for 30-60 minutes after the last bronchodilator dose 1, 2, 3